A 1-year analysis of adverse events following COVID-19 vaccination in Lebanon: a retrospective study
Abstract Background Since the deployment of Coronavirus Disease 2019 (COVID-19) vaccines, skepticism about the safety, incidence, and severity of Adverse Events Following Immunization (AEFI) was a concern. The study has two main objectives. First, to analyze AEFIs following COVID-19 vaccines (Pfizer...
Main Authors: | Abeer Zeitoun, Souheil Hallit, Sirine Chehade, Aya Ibrahim, Maya Helali, Carla Allam, Rita Karam |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-02-01
|
Series: | Journal of Pharmaceutical Policy and Practice |
Subjects: | |
Online Access: | https://doi.org/10.1186/s40545-023-00528-1 |
Similar Items
-
Vaccination process evaluation at COVID-19 vaccination centers in Lebanon: a national study
by: Abeer Zeitoun, et al.
Published: (2022-12-01) -
Adverse events with risankizumab in the real world: postmarketing pharmacovigilance assessment of the FDA adverse event reporting system
by: Yamin Shu, et al.
Published: (2023-05-01) -
Adverse events in patients with advanced urothelial carcinoma treated with erdafitinib: a retrospective pharmacovigilance study
by: Tengfei Yuan, et al.
Published: (2023-11-01) -
Adverse events following immunization associated with coronavirus disease 2019 (COVID-19) vaccines: A descriptive analysis from VigiAccess
by: Peter Yamoah, et al.
Published: (2022-11-01) -
A real-world study of antifibrotic drugs-related adverse events based on the United States food and drug administration adverse event reporting system and VigiAccess databases
by: Menglin He, et al.
Published: (2024-02-01)